Literature DB >> 3239377

Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy.

M J Cullen1, E Jaros.   

Abstract

Ultrastructurally there are some clear differences in the pathology of muscle in X chromosome-linked muscular dystrophy of the mouse (mdx) and Duchenne muscular dystrophy (DMD). In particular the mouse muscle does not become infiltrated by large aggregations of connective tissue. It has been proposed that the differences are due to secondary biochemical changes consequent on the absence of dystrophin in both conditions. If this is the case, attention should be directed to the earliest ultrastructural changes held in common by both disorders. The most conspicuous of these, preceding myofibril breakdown, is dilation of the sarcoplasmic reticulum. Any physiological link between this and the absence of dystrophin remains to be determined. We suggest that in the mdx mouse, the widespread myofibre necrosis occurring at 3-4 weeks is triggered by increased mechanical demands causing the lack of dystrophin to become critical at this time. Subsequent regeneration of the myofibres appears to be almost completely successful. The ultimate failure of regeneration in DMD, in contrast, may be due to an additional factors acting in DMD exacerbating the lack of dystrophin. This additional factor may be associated with the plasma membrane lesions (not seen in mdx). Alternatively there may be factors present in the mouse that compensate for the lack of dystrophin. It is pointed out that to understand better the different processes occurring in mdx and DMD we need to learn more about the factors which control the balance between the growth of muscle and the growth of connective tissue in both normal and pathological human and mouse muscle.

Entities:  

Mesh:

Year:  1988        PMID: 3239377     DOI: 10.1007/bf00688245

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  20 in total

Review 1.  Involvement of peripheral and central nerves in murine dystrophy.

Authors:  W G Bradley; E Jaros
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

2.  Histopathological changes in Duchenne muscular dystrophy.

Authors:  C D Bell; P E Conen
Journal:  J Neurol Sci       Date:  1968 Nov-Dec       Impact factor: 3.181

Review 3.  Morphological changes in dystrophic muscle.

Authors:  M J Cullen; F L Mastaglia
Journal:  Br Med Bull       Date:  1980-05       Impact factor: 4.291

4.  Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles.

Authors:  J W Carnwath; D M Shotton
Journal:  J Neurol Sci       Date:  1987-08       Impact factor: 3.181

5.  Regenerated muscle fibers in Duchenne muscular dystrophy: a serial section study.

Authors:  H Schmalbruch
Journal:  Neurology       Date:  1984-01       Impact factor: 9.910

6.  Conservation of the Duchenne muscular dystrophy gene in mice and humans.

Authors:  E P Hoffman; A P Monaco; C C Feener; L M Kunkel
Journal:  Science       Date:  1987-10-16       Impact factor: 47.728

7.  Muscle development in mdx mutant mice.

Authors:  J Dangain; G Vrbova
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

8.  The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates.

Authors:  L F Torres; L W Duchen
Journal:  Brain       Date:  1987-04       Impact factor: 13.501

9.  Histochemical fibre typing and ultrastructure of the small fibres in Duchenne muscular dystrophy.

Authors:  S C Watkins; M J Cullen
Journal:  Neuropathol Appl Neurobiol       Date:  1985 Nov-Dec       Impact factor: 8.090

10.  A qualitative and quantitative study of the ultrastructure of regenerating muscle fibres in Duchenne muscular dystrophy and polymyositis.

Authors:  S C Watkins; M J Cullen
Journal:  J Neurol Sci       Date:  1987-12       Impact factor: 3.181

View more
  32 in total

Review 1.  Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies.

Authors:  C A Collins; J E Morgan
Journal:  Int J Exp Pathol       Date:  2003-08       Impact factor: 1.925

2.  Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy.

Authors:  Stephanie A Parsons; Douglas P Millay; Michelle A Sargent; Elizabeth M McNally; Jeffery D Molkentin
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  IFN-γ promotes muscle damage in the mdx mouse model of Duchenne muscular dystrophy by suppressing M2 macrophage activation and inhibiting muscle cell proliferation.

Authors:  S Armando Villalta; Bo Deng; Chiara Rinaldi; Michelle Wehling-Henricks; James G Tidball
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

4.  Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients.

Authors:  Yetrib Hathout; Ramya L Marathi; Sree Rayavarapu; Aiping Zhang; Kristy J Brown; Haeri Seol; Heather Gordish-Dressman; Sebahattin Cirak; Luca Bello; Kanneboyina Nagaraju; Terry Partridge; Eric P Hoffman; Shin'ichi Takeda; Jean K Mah; Erik Henricson; Craig McDonald
Journal:  Hum Mol Genet       Date:  2014-07-15       Impact factor: 6.150

5.  A morphometric technique for the histological quantification of skeletal muscle regeneration.

Authors:  S A Marlow; J K McGeachie; M Tennant; J M Papadimitriou
Journal:  J Anat       Date:  1996-08       Impact factor: 2.610

6.  Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.

Authors:  Angus Lindsay; William M Southern; Preston M McCourt; Alexie A Larson; James S Hodges; Dawn A Lowe; James M Ervasti
Journal:  FEBS J       Date:  2019-04-11       Impact factor: 5.542

Review 7.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

8.  Effect of intraperitoneal injection of glucose on glucose oxidation and energy expenditure in the mdx mouse model of duchenne muscular dystrophy.

Authors:  A Mokhtarian; P C Even
Journal:  Pflugers Arch       Date:  1996-07       Impact factor: 3.657

9.  Dystrophin deficiency is associated with myotendinous junction defects in prenecrotic and fully regenerated skeletal muscle.

Authors:  D J Law; J G Tidball
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

10.  Imatinib attenuates skeletal muscle dystrophy in mdx mice.

Authors:  Ping Huang; Xinyu S Zhao; Matthew Fields; Richard M Ransohoff; Lan Zhou
Journal:  FASEB J       Date:  2009-03-16       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.